Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

  1. Oberthuer, A.
  2. Juraeva, D.
  3. Hero, B.
  4. Volland, R.
  5. Sterz, C.
  6. Schmidt, R.
  7. Faldum, A.
  8. Kahlert, Y.
  9. Engesser, A.
  10. Asgharzadeh, S.
  11. Seeger, R.
  12. Ohira, M.
  13. Nakagawara, A.
  14. Scaruffi, P.
  15. Tonini, G.P.
  16. Janoueix-Lerosey, I.
  17. Delattre, O.
  18. Schleiermacher, G.
  19. Vandesompele, J.
  20. Speleman, F.
  21. Noguera, R.
  22. Piqueras, M.
  23. Bénard, J.
  24. Valent, A.
  25. Avigad, S.
  26. Yaniv, I.
  27. Grundy, R.G.
  28. Ortmann, M.
  29. Shao, C.
  30. Schwab, M.
  31. Eils, R.
  32. Simon, T.
  33. Theissen, J.
  34. Berthold, F.
  35. Westermann, F.
  36. Brors, B.
  37. Fischer, M.
  38. Show all authors +
Journal:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Year of publication: 2015

Volume: 21

Issue: 8

Pages: 1904-1915

Type: Article

DOI: 10.1158/1078-0432.CCR-14-0817 GOOGLE SCHOLAR lock_openOpen access editor